bg2109
Showing 1 - 2 of 2
Assisted Reproductive Technology, Controlled Ovarian Hyperstimulation Trial in China (BG2109, Cetrorelix)
Not yet recruiting
- Assisted Reproductive Technology
- Controlled Ovarian Hyperstimulation
- BG2109
- Cetrorelix
-
Changsha, China
- +9 more
Feb 21, 2023
Uterine Fibroids, Heavy Menstrual Bleeding Trial in China (BG2109, Placebo for BG2109, Placebo for add-back therapy)
Recruiting
- Uterine Fibroids
- Heavy Menstrual Bleeding
- BG2109
- +3 more
-
Beijing, China
- +30 more
Nov 10, 2022